4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-013071
CHIEF OPERATING OFFICER sold 260 shares at $25.06 ($6,515)
- CHIEF OPERATING OFFICER acquired 260 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Anish CHIEF OPERATING OFFICER | 2024-05-09 | Option exercise 10b5-1 | +260 | $2.48 | $645 | 260 | D: show line 1 in the form |
| Patel Anish CHIEF OPERATING OFFICER | 2024-05-09 | Sale 10b5-1 | −260 | $25.06 | $6,515 | 0 | D: show line 2 in the form |
| Open-market sales · 260 sh · avg $25.06 · $6,515 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Anish CHIEF OPERATING OFFICER | 2024-05-09 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −260 | 55,582 | D: show line 3 in the form |
Loading xslF345X05/form4-05132024_110543.xml…